Drug
Iodinated contrast agents
Iodinated contrast agents is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
100%(2 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Other(1)
Detailed Status
Completed2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Trials by Status
unknown133%
completed267%
Recent Activity
0 active trials
Showing 3 of 3
unknown
Serum Thyroid Function After Iodinated Contrast Administration
NCT05786846
completed
Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States
NCT02959827
completed
Observational Study on Hypothyroidism in Young Children Following Iodine Contrast Exposure
NCT02766283
Clinical Trials (3)
Showing 3 of 3 trials
NCT05786846
Serum Thyroid Function After Iodinated Contrast Administration
NCT02959827
Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States
NCT02766283
Observational Study on Hypothyroidism in Young Children Following Iodine Contrast Exposure
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3